vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and BillionToOne, Inc. (BLLN). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $74.5M, roughly 1.1× AMERICAN SUPERCONDUCTOR CORP). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs 6.8%, a 151.2% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 21.4%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $2.4M).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
AMSC vs BLLN — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $83.5M |
| Net Profit | $117.8M | $5.7M |
| Gross Margin | 30.7% | 69.9% |
| Operating Margin | 4.5% | 11.5% |
| Net Margin | 158.1% | 6.8% |
| Revenue YoY | 21.4% | 117.4% |
| Net Profit YoY | 4679.1% | 138.3% |
| EPS (diluted) | $2.62 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | — | ||
| Q3 25 | $65.9M | $83.5M | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $66.7M | — | ||
| Q4 24 | $61.4M | — | ||
| Q3 24 | $54.5M | $38.4M | ||
| Q2 24 | $40.3M | — | ||
| Q1 24 | $42.0M | — |
| Q4 25 | $117.8M | — | ||
| Q3 25 | $4.8M | $5.7M | ||
| Q2 25 | $6.7M | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $4.9M | $-14.9M | ||
| Q2 24 | $-2.5M | — | ||
| Q1 24 | $-1.6M | — |
| Q4 25 | 30.7% | — | ||
| Q3 25 | 31.0% | 69.9% | ||
| Q2 25 | 33.8% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 28.7% | 52.6% | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.5% | 11.5% | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | -1.4% | -32.9% | ||
| Q2 24 | -8.2% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 158.1% | — | ||
| Q3 25 | 7.2% | 6.8% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.0% | -38.8% | ||
| Q2 24 | -6.3% | — | ||
| Q1 24 | -3.8% | — |
| Q4 25 | $2.62 | — | ||
| Q3 25 | $0.11 | $0.10 | ||
| Q2 25 | $0.17 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.13 | $-1.47 | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $195.2M |
| Total DebtLower is stronger | — | $55.0M |
| Stockholders' EquityBook value | $536.8M | $-239.5M |
| Total Assets | $719.5M | $327.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | — | ||
| Q3 25 | $212.9M | $195.2M | ||
| Q2 25 | $207.9M | — | ||
| Q1 25 | $79.5M | — | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $72.1M | — | ||
| Q2 24 | $93.5M | — | ||
| Q1 24 | $90.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $536.8M | — | ||
| Q3 25 | $342.2M | $-239.5M | ||
| Q2 25 | $333.1M | — | ||
| Q1 25 | $197.1M | — | ||
| Q4 24 | $192.7M | — | ||
| Q3 24 | $187.0M | $-242.9M | ||
| Q2 24 | $143.3M | — | ||
| Q1 24 | $144.6M | — |
| Q4 25 | $719.5M | — | ||
| Q3 25 | $445.6M | $327.5M | ||
| Q2 25 | $452.8M | — | ||
| Q1 25 | $310.5M | — | ||
| Q4 24 | $310.3M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $240.1M | — | ||
| Q1 24 | $232.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $13.8M |
| Free Cash FlowOCF − Capex | $2.4M | $6.5M |
| FCF MarginFCF / Revenue | 3.2% | 7.7% |
| Capex IntensityCapex / Revenue | 1.2% | 8.8% |
| Cash ConversionOCF / Net Profit | 0.03× | 2.42× |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | — | ||
| Q3 25 | $6.5M | $13.8M | ||
| Q2 25 | $4.1M | — | ||
| Q1 25 | $6.3M | — | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $2.2M | — |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $5.1M | $6.5M | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $12.1M | — | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $1.9M | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 7.7% | 7.7% | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.1% | 8.8% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | 2.42× | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
